logo of the vendor
Pharma Intelligence UK Ltd logo

Preserving product integrity across the entire supply chain

thumbnail of content

The biologics industry is expected to continue its rapid growth, with the market predicted to reach around $240m by 2025 at an annual rate of 9.9%. As vaccines represent a large segment of expansion, the demand for seamless and efficient cold chain management has never been more critical.

Thermo Fisher Scientific explore the pivotal role of their expert end-to-end services, including:

  • Driving efficacy and quality of products with cold chain management
  • Leveraging regional expertise and supply chain management
  • Navigating regulations with expertise of QPs
  • Utilizing advanced tracking and monitoring systems
  • Outsourcing biorepositories and appointing logistics providers
  • Delivering integrated cold chain services across Europe

Read the Article

Opt In?

Please complete all required fields to access the content!

Explore similar content

IQVIA
Pharma Intelligence UK Ltd

Future-Ready Pharmacovigilance: Integrating AI With FDA's EDSTP Guidelines

Join IQVIA’s esteemed panel of experts for an in-depth discussion on how AI can meet and exceed these new expectations. This webinar delves into the intersection of regulatory frameworks and technological innovation, offering insights into the future of PV and how organizations can navigate this transformative field. Key takeaways include:
Webinar Clinical Studies Pharmaceutical Research and Development
ThermoFisher
Pharma Intelligence UK Ltd

Accelerating Biologics Development With Strategies For Success

The biologics market is growing rapidly, unlocking exciting opportunities but also presenting significant challenges. Developers are undergoing pressure to accelerate the delivery of innovative therapies while addressing complex regulatory demands, navigating demanding clinical trial phases, efficiently scaling production, and maintaining quality. In this webinar, industry experts will share practical strategies and real-world examples to help you navigate these challenges. Key takeaways:
Webinar Clinical Studies Pharmaceutical Research and Development
IQVIA Technologies
Pharma Intelligence UK Ltd

A New Era of Participant Payment Services

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering:
Article Clinical Studies Pharmaceutical Research and Development